Research
Topics:
INDEX
AI-chat 1
PRIME 18
aging 9
body 2
brain 10
cancer 11
censorship 1
cognition 4
covid-19 1
culture 2
dental 1
diabetes 1
gender 2
genetics 2
heart 8
immune 5
kidneys 6
language 1
lungs 7
metabolism 3
microbiome 3
nutrition 6
obesity 2
pain 2
physical 2
politics 2
pollution 2
practice 1
privacy 2
psychology 4
reproduction 1
rights 1
sleep 3
tech 1
virus 2
war-confl
 
Scanned: 2759
Evaluated: 288
Selected: 68
 
    CANCER    LUNGS   

Mbr03-004

Serum Tumor Marker Profiles in Interstitial Lung Diseases: Implications for Differential Diagnosis and Disease Severity Assessment

Quote:Conclusion CEA, CA199, and CA125 aid in distinguishing ILD subtypes, while CEA, NSE, and CYFRA 21-1 correlate with impaired gas exchange. The combined clinical and biomarker model demonstrated superior performance in discriminating IPF from CTD-ILD, highlighting its clinical potential.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.13.26344081v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.13.26344081v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Yingying Du Xuxiang Song Qunli Ding, 
    CANCER    LUNGS   

Mbr03-014

Longitudinal Analysis of CYFRA 21-1 Levels in Patients with Pulmonary Nodules: Differential Trajectories Between Benign and Malignant Cases and Impact of Tumor Resection

Quote:Conclusions CYFRA 21-1 exhibits substantial within-patient variability over time, with trajectories that reflect disease state and treatment. These findings suggest that longitudinal monitoring of CYFRA 21-1analogous to PSA velocity in prostate cancer may offer improved diagnostic and prognostic insight in the evaluation of pulmonary nodules. Further studies in larger cohorts are warranted to validate these findings and explore clinical implementation of CYFRA trajectory analysis
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.10.26343848v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.10.26343848v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Yency J. Forero Michael N. Kammer Kevin C. McGann Sheau-Chiann Chen Heidi Chen Samson Argaw Timothy A. Khalil Sanja L. Antic Yong Zou Zuo Lianrui Thomas A. Lasko Bennet A. Landman Stephen A. Deppen Eric L. Grogan Fabien Maldonado, 
    CANCER    IMMUNE   

Mca03-002

Multimodal single-cell and spatial profiling reveals altered T cell-mediated immunity and B-cell follicular architecture in non-metastatic lymph nodes of patients with aggressive non-small cell lung cancer

Abstract: https://www.medrxiv.org/content/10.64898/2026.01.12.25343268v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.12.25343268v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Zhan Hao Xi Yusuke Koga Shannon McDermott Erin Kane Roxanna Pfefferkorn Ehab Billatos Paul R Hosking Jennifer Beane Eric J. Burks Sarah A Mazzilli Kei Suzuki Joshua D Campbell, 
    CANCER   

Mca03-014

Monitoring of plasma and urine tumor-derived DNA to inform bladder-sparing approaches for patients with muscle-invasive bladder cancer

Quote:Urine utDNA was more sensitive than plasma ctDNA at detecting residual disease within the bladder, and detectable urine utDNA in patients with a complete clinical response was associated with shorter bladder-intact survival HR 6.47, 95 CI 1.34-31.31; log-rank p0.008. These findings establish the conceptual and experimental foundation for incorporating ctDNA and utDNA assays into the management of patients with MIBC, particularly with respect to the need for cystectomy.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.14.26344033v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.14.26344033v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Matthew D Galsky Sudeh Izadmehr Menggang Yu Samuel D Curtis Christopher Douville Maria Popoli Janine Ptak Lisa Dobbyn Natalie Silliman Kevin G Chan Tanya B Dorff Jeremy Paul Cetnar Brock ONeil Anishka DSouza Ronac Mamtani Christos E Kyriakopoulos Rachel Brody Evita Sadimin Reza Mehrazin Diego Chowell John Sfakianos Siamak Daneshmand Sumanta K Pal Chetan Bettegowda Kenneth W Kinzler Nickolas Papadopoulos Bert Vogelstein Yuxuan Wang, 
    PRIME    CANCER   

Mca03-016

Personalized Autoantibody Profiling Distinguishes Earlystage Breast Cancer from Benign Disease

Quote:Conclusions This study identifies an eight-antibody panel with promising diagnostic potential to distinguish benign breast disease from early-stage breast cancer. The z-score normalization approach and analysis of individual donors high-titer antibody profiles represent a novel approach towards personalized cancer immunology.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.15.26344214v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.15.26344214v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Kathryn A. Lyon Justin C. Rolando David R. Walt, 
    CANCER   

Mca03-018

Differentiating Borderline HER2-Expressing and HER2-Positive Cancers from Other Subtypes Using Serum Urokinase Plasminogen Activator

Quote:Conclusions The established liquid biopsy test for serum uPA has potential for accurate diagnosis and staging of patients with HER2 cancers and borderline cancers requiring further confirmatory or rejection testing.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.15.26344197v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.15.26344197v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Michael E. J. Lopez Mujica Suchanat Boonkaew Nana Louise Christensen Mette Abildgaard Pedersen Kit Riegels Jorgensen Mikkel Vendelbo Elena Ferapontova, 
    CANCER   

Mca03-020

Hypomethylation on cfDNA within transposable elements can predict ovarian malignancy in women with adnexal masses

Quote:Conclusions We developed two multivariate models based on cfDNA-derived 5hmC or 5mC modified transposable elements to accurately predict ovarian malignancy in women. Furthermore, we show that our 5hmC-based model applies to plasma EDTA and serum samples, which are commonly collected in clinical practice. The results of our study warrant further investigation of the predictive performance of our models in large-scale cohorts in the future.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.14.26344128v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.14.26344128v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Melanie Weigert Xiaolong Cui Peiihong Zhang Krissana Kowitwanich Diana West-Szymanski Sarah Rauch Wei Zhang Chuan He Ernst Lengyel, 
    CANCER   

Mcr03-020

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study

Abstract: https://www.medrxiv.org/content/10.64898/2026.01.14.26344055v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.14.26344055v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Emily S.L. Martens Bram Akerboom Christine Baumgartner Rolf E. Brouwer Chiara Cavallaro Michiel Coppens Giorgio Costantino Francis Couturaud Alessandro DErrico Yordi P.A. van Dooren Francesca Gianni Rene van der Griend Marco J.J.H. Grootenboers Olivier Hugli Tom van der Hulle Zahra Jaderi David Jimenez Pieter Willem Kamphuisen Vincent R. Lanting Jenneke Leentjens Martje L. Maas Isabelle Mahe Oene A. van Meer Thijs E. van Mens Mattijs Out Roberto Pola Damiana Pulver Jo Raskin Marc Righini Reinier A. Sprenger Milou A.M. Stals Rossella Talerico Tobias Tritschler Marije ten Wolde Menno V. Huisman Frederikus A. Klok, 
    CANCER    VIRUS   

Mep03-016

Population-based cervical screening with Human Papillomavirus self-sampling at home and incidence of cervical cancer

Quote:Conclusions A rapid introduction of primary HPV self-sampling at home in 2020-2021 was followed by a rapid decline in invasive cervical cancer incidence.
Abstract: https://www.medrxiv.org/content/10.64898/2026.01.15.26344201v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.15.26344201v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Helena Andersson Joakim Dillner, 
    CANCER   

Mur03-006

Mass spectrometry and machine learning for classification and molecular phenotyping of renal cell carcinoma and benign tumors

Abstract: https://www.medrxiv.org/content/10.64898/2026.01.13.26343935v1
Full Text: https://www.medrxiv.org/content/10.64898/2026.01.13.26343935v1.full-text
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
Search Authors: Andreas A. Thomsen Maj Rabjerg Niels Marcussen Lars Lund Ole N. Jensen, 
    PRIME    CANCER    MICROBIOME   

Zac03-005

Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition EMT in Human Breast Cancer Cells

Quote:According to previous reports, the efficacy of mummy associated with humic and fulvic acids, which are essential for its biochemical functions that these compounds represented to be very effective in decreasing inflammation, pain, arthritis, ulcer, diabetes, stress, anxiety, and the most importantly inducing the cell apoptosis in many cancers. Mummy, as a water-soluble non-toxic and inexpensive compound, can be consumed as a part of the daily diet 10 thus, further studies required to investigate the therapeutic effects of mummy and its active constituents as suitable candidates for chemotherapy.
Comment: Iranians call it Mummy, Tibetans call it shilajit
Article: https://pmc.ncbi.nlm.nih.gov/articles/PMC8343979/
Search Similar: Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho 
See Also:
  • https://breastcancerconqueror.com/category/7-essentials-6/

    •   Updated weekly. 01/24/2026-02:51:25 AM
    Javilk's Research Links
    Drop me a note to subscribe.
    What interests you?